Lexaria Bioscience Ownership | Who Owns Lexaria Bioscience?

Lexaria Bioscience Ownership Summary

Lexaria Bioscience is owned by 7.66% institutional investors, 7.03% insiders, and 85.31% retail investors. Invenomic capital management lp is the largest institutional shareholder, holding 3.71% of LEXX shares. Invenomic Institutional is the top mutual fund, with 1.15% of its assets in Lexaria Bioscience shares.

LEXX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lexaria Bioscience	7.66%	7.03%	85.31%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Invenomic capital management lp	513.57K	3.71%	$1.43M
Geode capital management	114.78K	0.83%	$319.19K
Vanguard group	93.59K	0.68%	$260.17K
Gentrust	60.00K	0.43%	$166.80K
Raymond james financial services advisors	48.80K	0.35%	$135.66K
State street	39.30K	0.28%	$109.26K
Blackrock	27.45K	0.20%	$76.30K
Morgan stanley	22.98K	0.17%	$63.89K
Northern trust	18.39K	0.13%	$51.12K
Xtx topco	12.60K	0.09%	$35.03K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Invenomic capital management lp	513.57K	0.07%	$1.43M
Byrne asset management	13.00K	0.02%	$27.30K
Gentrust	60.00K	0.01%	$166.80K
Xtx topco	12.60K	0.00%	$35.03K
Oakworth capital	5.00K	0.00%	$10.50K
Raymond james financial services advisors	48.80K	0.00%	$135.66K
Tower research capital llc (trc)	3.37K	0.00%	$9.37K
Wealth enhancement advisory services	13.82K	0.00%	$42.16K
Bank of america corp /de/	96.00	-	$267.00
Advisor group	2.29K	-	$6.37K

Top Buyers

Holder	Shares	% Assets	Change
Gentrust	60.00K	0.01%	60.00K
Invenomic capital management lp	513.57K	0.07%	40.31K
Blackrock	27.45K	-	25.94K
Geode capital management	114.78K	-	15.45K
Raymond james financial services advisors	48.80K	0.00%	9.25K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-1.02M
Welch group	-	-	-24.00K
Renaissance	-	-	-22.80K
Citadel advisors	-	-	-15.86K
Adar1 capital management	-	-	-945.00

New Positions

Holder	Shares	% Assets	Change	Value
Gentrust	60.00K	0.01%	60.00K	$166.80K

Sold Out

Holder	Change
Toronto dominion bank	-13.00
Allworth financial lp	-89.00
Mather group, llc.	-100.00
Aspire private capital	-400.00
Adar1 capital management	-945.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	26	-7.14%	1,061,074	-48.44%	7	3.47%	10	-28.57%	4	33.33%
Jun 30, 2024	28	12.00%	2,057,835	131.53%	14	21.79%	14	-12.50%	3	-
Mar 31, 2024	25	31.58%	888,794	-25.66%	8	4.73%	16	60.00%	3	-25.00%
Dec 31, 2023	19	35.71%	1,195,589	-32.50%	13	1.84%	10	66.67%	4	-
Sep 30, 2023	14	16.67%	1,771,138	98.50%	26	13.95%	6	100.00%	4	33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Invenomic Institutional	200.65K	1.15%	-62.77K
Vanguard Institutional Extnd Mkt Idx Tr	117.23K	0.67%	-
Fidelity Extended Market Index	80.00K	0.46%	-527.00
Fidelity Total Market Index	26.37K	0.15%	-
BlackRock Extended Equity Market K	22.61K	0.14%	-10.00
Extended Equity Market Fund K	22.30K	0.13%	-307.00
Fidelity Series Total Market Index	19.13K	0.11%	-602.00
Northern Trust Extended Eq Market Idx	12.25K	0.08%	-
NT Ext Equity Mkt Idx Fd - L	12.25K	0.07%	-
Vanguard U.S. Eq Idx £ Acc	10.20K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 02, 2024	CHRISTOPHER RICHARD	Chief Executive Officer	Buy	$51.22K
Dec 03, 2024	CHRISTOPHER RICHARD	Chief Executive Officer	Buy	$67.17K
Aug 12, 2024	TURKEL CATHERINE C.	-	Buy	$5.01K
Jul 31, 2024	Carle Vanessa	Secretary	Sell	$10.27K
Feb 09, 2023	TURKEL CATHERINE C.	-	Buy	$4.27K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q3	1	1
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

LEXX Ownership FAQ

Who Owns Lexaria Bioscience?

Lexaria Bioscience shareholders are primarily institutional investors at 7.66%, followed by 7.03% insiders and 85.31% retail investors. The average institutional ownership in Lexaria Bioscience's industry, Biotech Stocks , is 109.70%, which Lexaria Bioscience falls below.

Who owns the most shares of Lexaria Bioscience?

Lexaria Bioscience’s largest shareholders are Invenomic capital management lp (513.57K shares, 3.71%), Geode capital management (114.78K shares, 0.83%), and Vanguard group (93.59K shares, 0.68%). Together, they hold 5.21% of Lexaria Bioscience’s total shares outstanding.

Does Blackrock own Lexaria Bioscience?

Yes, BlackRock owns 0.20% of Lexaria Bioscience, totaling 27.44K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 76.3K$. In the last quarter, BlackRock increased its holdings by 25.94K shares, a 1719.96% change.

Who is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested?

Invenomic capital management lp is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested, with 0.07% of its assets in 513.57K Lexaria Bioscience shares, valued at 1.43M$.

Who is the top mutual fund holder of Lexaria Bioscience shares?

Invenomic Institutional is the top mutual fund holder of Lexaria Bioscience shares, with 1.15% of its total shares outstanding invested in 200.65K Lexaria Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools